|
Volumn 173, Issue 2, 2015, Pages 323-
|
MicroRNAs in psoriasis: Leaders or followers?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
ETANERCEPT;
INTERLEUKIN 8;
MICRORNA;
MICRORNA 146A;
MICRORNA 21;
MICRORNA 31;
TUMOR NECROSIS FACTOR INHIBITOR;
ANTIINFLAMMATORY AGENT;
MESSENGER RNA;
CANCER PROGNOSIS;
CANCER THERAPY;
DISEASE COURSE;
GENE EXPRESSION;
GENE EXPRESSION PROFILING;
GENE REPRESSION;
GENETIC ASSOCIATION;
GENETIC SCREENING;
GENETIC TRANSCRIPTION;
GENETIC VARIABILITY;
HISTOLOGY;
HUMAN;
IMMUNE SYSTEM;
INFLAMMATION;
LIVER CANCER;
MOLECULAR BIOLOGY;
NONHUMAN;
NOTE;
PATHOGENESIS;
PERSONALIZED MEDICINE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PSORIASIS;
PUNCH BIOPSY;
SKIN DISEASE;
UPREGULATION;
ANIMAL;
FEMALE;
MALE;
METABOLISM;
ADALIMUMAB;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
FEMALE;
HUMANS;
MALE;
MICRORNAS;
PSORIASIS;
RNA, MESSENGER;
|
EID: 84941046235
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/bjd.13837 Document Type: Note |
Times cited : (6)
|
References (7)
|